G. Svegliati-Baroni
Molecular Biology · 2018
A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 30 citations into it
- Epidemiology — 27 citations into it
- Surgery — 17 citations into it
- Hepatology — 10 citations into it
- Endocrinology, Diabetes and Metabolism — 7 citations into it
Whom G. Svegliati-Baroni trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from G. Svegliati-Baroni's perspective
Ordered by how strongly the researchers G. Svegliati-Baroni trusts endorse each paper. Same corpus, a different order for every researcher.
- An obesity-associated gut microbiome with increased capacity for energy harvest (Nature)
- Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. (Cell Metabolism)
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity (Nature)
- Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation (Nature)
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH (Hepatology)
- The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis (Immunity)
- Inflammasome is a central player in the induction of obesity and insulin resistance (Proceedings of the National Academy of Sciences of the United States of America)
- TGR5-mediated bile acid sensing controls glucose homeostasis. (Cell Metabolism)
- Host-Bacterial Mutualism in the Human Intestine (Science)
- FXR is a molecular target for the effects of vertical sleeve gastrectomy (Nature)
Their papers
- Lipotoxicity and the gut-liver axis in NASH pathogenesis. (2018) — 749 citations